Akt signaling pathway in pacing-induced heart failure.
Marked changes in energy substrate utilization occur during the progression of congestive heart failure (CHF) where fatty acid utilization, as the primary source of cardiac energy, is severely diminished, oxidative phosphorylation is down-regulated, and glucose uptake and utilization increase. Neither the signaling events or the molecular basis for the shift in substrate utilization have yet been elucidated. This study was designed to examine in the canine model of paced-induced CHF, the potential role of the Akt pathway in signaling the metabolic transitions central to progression to heart failure. Myocardial Akt levels were elevated in early heart failure (after 1-2 weeks of pacing) accompanied by increased levels of oxidative stress, cytokine tumor necrosis factor-alpha (TNF-alpha) and free fatty acid accumulation, reduced activity levels of mitochondrial respiratory complexes III and V and apoptosis initiation. At severe heart failure (3-4 weeks of pacing), there was significant further increase in myocardial apoptosis, with pronounced decline in myocardial Akt kinase activity. At this later stage, there were no further changes in free fatty acid accumulation, complex V activity or in oxidative stress levels indicating that these changes primarily occurred in the earlier stage of evolving heart failure. In contrast, during severe heart failure, both the reduction in complex III activity and increase in TNF-alpha level became more pronounced. Our data provide critical support for the hypothesis that the Akt signaling pathway is a contributory element in the early signaling events leading to the progression of pacing-induced heart failure, accompanying the shift in substrate utilization.
Ananthakrishnan
Radha
R
The Molecular Cardiology and Neuromuscular Institute, Highland Park, NJ 08904, USA.
Moe
Gordon W
GW
Goldenthal
Michael J
MJ
Marín-García
José
J
D000818:Animals; D017209:Apoptosis; D004285:Dogs; D014450:Electron Transport Complex III / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism; D006333:Heart Failure / Q000503:physiopathology*; D018384:Oxidative Stress; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt; D015398:Signal Transduction; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D005227:Fatty Acids; D011518:Proto-Oncogene Proteins; D014409:Tumor Necrosis Factor-alpha; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt; D014450:Electron Transport Complex III
Cell Cycle. 2003 May-Jun;2(3):220-3
12734428
Anal Biochem. 1995 Jul 1;228(2):294-8
8572309
Cardiovasc Res. 1991 Jun;25(6):468-74
1889061
Lab Invest. 1995 Dec;73(6):771-87
8558838
Biochemistry. 2003 Mar 18;42(10 ):2995-3003
12627965
Herz. 2002 Nov;27(7):662-8
12439637
J Biol Chem. 1997 Sep 26;272(39):24154-8
9305864
Circ Res. 2000 Jun 23;86(12):1252-8
10864916
FASEB J. 2002 Nov;16(13):1732-7
12409315
Pathophysiology. 2002 Jun;8(3):183-192
12039650
Cardiovasc Res. 1992 Apr;26(4):362-6
1638568
Circulation. 1996 Dec 1;94(11):2837-42
8941110
Genes Dev. 1999 Nov 15;13(22):2905-27
10579998
Circulation. 2002 Jul 30;106(5):606-12
12147544
J Biol Chem. 2002 Jun 21;277(25):22528-33
11956204
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12333-8
12237475
Cell Death Differ. 2003 Jul;10 (7):772-81
12815460
Cell. 1997 Oct 17;91(2):231-41
9346240
Cardiovasc Res. 2001 Oct;52(1):103-10
11557238
J Nucl Med. 2001 Jan;42(1):124-9
11197960
EMBO J. 2003 Oct 15;22(20):5501-10
14532122
Cardiovasc Res. 1999 Jun;42(3):591-9
10533598
Am J Physiol Heart Circ Physiol. 2002 Apr;282(4):H1288-95
11893563
J Biol Chem. 2003 Oct 10;278(41):39422-7
12890675
Cardiovasc Res. 2000 Feb;45(3):595-602
10728381
Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1861-8
11247802
J Biol Chem. 2004 Feb 6;279(6):4782-93
14597618
Circulation. 1999 Dec 7;100(23 ):2373-9
10587343
Am J Physiol Heart Circ Physiol. 2002 Sep;283(3):H1056-64
12181135
J Mol Cell Cardiol. 1997 Jan;29(1):265-72
9040041
FEBS Lett. 1997 Jun 30;410(2-3):493-8
9237690
Circ Res. 1998 Nov 16;83(10):969-79
9815144
Am J Cardiol. 1999 Jun 17;83(12A):64H-69H
10750590
J Biol Chem. 2002 May 31;277(22):19255-64
11907032
Circulation. 2003 Mar 18;107(10):1418-23
12642364
Am J Physiol Heart Circ Physiol. 2003 Apr;284(4):H1313-20
12626329
J Card Fail. 2002 Dec;8(6 Suppl):S359-69
12555146
Cardiovasc Res. 2004 Feb 1;61(2):297-306
14736546
Circulation. 1995 Oct 15;92(8):2306-17
7554216